Cargando…

Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: Design of the EDORA randomized clinical trial

BACKGROUND: Atrial fibrillation (AF) recurrence after catheter ablation is associated with worse outcomes and quality of life. Left atrial (LA) structural remodeling provides the essential substrate for AF perpetuation. Baseline extent and the progression of LA fibrosis after ablation are strong pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrouche, Nassir F., Dagher, Lilas, Wazni, Oussama, Akoum, Nazem, Mansour, Moussa, El Hajjar, Abdel Hadi, Bhatnagar, Arezu, Hua, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298087/ https://www.ncbi.nlm.nih.gov/pubmed/34664772 http://dx.doi.org/10.1111/jce.15274

Ejemplares similares

Esophageal temperature during atrial fibrillation ablation poorly predicts esophageal injury: An observational study
por: Ayoub, Tarek, et al.
Publicado: (2021)

Cardiac MRI to Manage Atrial Fibrillation
por: Zhao, Yan, et al.
Publicado: (2020)

Atrial Fibrillation and Acute Ischemic Stroke: Evaluation of the Contemporary 2018 National Inpatient Sample Database
por: Sidhu, Gursukhman D.S., et al.
Publicado: (2022)

Postablation Right Atrial Dissection in Ebstein's Anomaly
por: Hassan, Fatemat, et al.
Publicado: (2017)

Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study
por: Blomström‐Lundqvist, Carina, et al.
Publicado: (2020)

Dronedarone in the management of atrial fibrillation
por: Saleem, TS Mohamed, et al.
Publicado: (2010)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Fibrinolytic Deficit and Platelet Activation in Atrial Fibrillation and Their Postablation Modulation
por: Otto, Abigail, et al.
Publicado: (2018)

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010)

Computational Shape Models Characterize Shape Change of the Left Atrium in Atrial Fibrillation
por: Cates, Joshua, et al.
Publicado: (2015)

Commentary: Postablation atrial-esophageal fistula—the way to a man's heart?
por: MacGillivray, Thomas E., et al.
Publicado: (2020)

Substrate Modification Is a Better Predictor of Catheter Ablation Success in Atrial Fibrillation Than Pulmonary Vein Isolation: An LGE-MRI Study
por: Akoum, Nazem, et al.
Publicado: (2015)

Management of atrial fibrillation: focus on the role of dronedarone
por: Cheng, Judy WM
Publicado: (2011)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
por: Christiansen, Christine Benn, et al.
Publicado: (2010)

Dronedarone for atrial fibrillation: a new therapeutic agent
por: Patel, Pawan D, et al.
Publicado: (2009)

Cost considerations in the management of atrial fibrillation – impact of dronedarone
por: Khaykin, Yaariv, et al.
Publicado: (2012)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
por: Trigo, Paula, et al.
Publicado: (2012)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011)

Elevated liver enzymes associated with dronedarone for atrial fibrillation
por: Ragucci, Kelly R
Publicado: (2013)

Dronedarone-induced Phototoxicity in a Patient with Atrial Fibrillation
por: Datar, Praveen, et al.
Publicado: (2019)

The role of adiposity in atrial fibrillation pathogenesis – An area of growing scientific and clinical interest
por: Chahine, Yaacoub, et al.
Publicado: (2021)

Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation
por: Saengklub, Nakkawee, et al.
Publicado: (2017)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS
por: Naccarelli, Gerald V, et al.
Publicado: (2014)

A cardiovascular clinic patients’ survey to assess challenges and opportunities of digital health adoption during the COVID-19 pandemic
por: Dagher, Lilas, et al.
Publicado: (2021)

Postablation Atrial Fibrillation Burden and Patient Activity Level: Insights From the DISCERN AF Study
por: Proietti, Riccardo, et al.
Publicado: (2018)

Radiomic Phenotype of Periatrial Adipose Tissue in the Prognosis of Late Postablation Recurrence of Idiopathic Atrial Fibrillation
por: Ilyushenkova, J.N., et al.
Publicado: (2023)

Postablation Endometrial Carcinoma
por: Wortman, Morris, et al.
Publicado: (2017)

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation
por: Schweizer, Patrick A, et al.
Publicado: (2011)

Addressing the management of atrial fibrillation – a systematic review of the role of dronedarone
por: Podda, Gian Marco, et al.
Publicado: (2012)

Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
por: Sullivan, Renee M, et al.
Publicado: (2010)

Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone
por: Chahal, C Anwar A, et al.
Publicado: (2012)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
por: Zhang, Mengran, et al.
Publicado: (2021)

Amiodarone vs Dronedarone for Atrial Fibrillation: A Retrospective Cohort Study
por: Brophy, James M., et al.
Publicado: (2022)

MRI-quantified left atrial epicardial adipose tissue predicts atrial fibrillation recurrence following catheter ablation
por: Chahine, Yaacoub, et al.
Publicado: (2022)

Alcohol Consumption Is Associated With Postablation Recurrence but Not Changes in Atrial Substrate in Patients With Atrial Fibrillation: Insight from a High‐Density Mapping Study
por: Sagawa, Yuichiro, et al.
Publicado: (2022)

Managing Postablation Pericardial Effusion
Publicado: (2018)

PO-703-02 DIGITAL HEALTH DEVICE DEMONSTRATES THE LONG-TERM IMPACT OF COVID-19 ON THE CARDIOVASCULAR AND AUTONOMIC SYSTEM
por: DAGHER, Lilas, et al.
Publicado: (2022)

Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter
por: Kim, Michael H., et al.
Publicado: (2014)

Regional left atrial wall fibrosis and recurrence after atrial fibrillation ablation
por: Bieging, Erik T, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tlmhnlkm6nii2ppqmfr6fvalq4